Study guide
Acne Mechanisms, Severity Descriptions, and Cosmetic Decisions
Virginia Master Esthetics License Exam Exam
Track your progress as you read
Finished sections get a check mark.
1 Exam Preparation and Practical Walkthroughs
Current Exam Structure, Scheduling, and a Study Plan Practical Walkthrough: First Client, Cleansing, MLD, Particles, and LED Practical Walkthrough: New Client, Ultrasound, Microcurrent, AHA, Body, and Blood
2 Infection Control and Occupational Safety
Microorganisms, Disease Causes, and Transmission Cleaning, Disinfection, Product Labels, and Tool Storage Sterilization, Monitoring, Packaging, and Sharps OSHA Bloodborne Pathogens and Exposure Response
3 Skin Histology, Barrier, Appendages, and Repair
Epidermal Layers, Cells, Renewal, and Barrier Significance Dermal Organization, Matrix, Vessels, and Sensation Barrier Lipids, Hydration, Acid Mantle, and TEWL Skin Appendages, Secretions, and Wound-Healing Phases
4 Facial Anatomy, Circulation, and Lymphatic Pathways
Facial Expression, Mastication, Cranial Nerves, and Regional Caution Head and Neck Vessels, Filtration, and Referral Concerns Lymphatic Vessels, Nodes, Territories, and Venous Return
5 Skin Findings, Conditions, and Referral
Primary and Secondary Lesion Morphology and Referral Acne Mechanisms, Severity Descriptions, and Cosmetic Decisions Rosacea Features, Historical Subtypes, and Sensitive-Skin Decisions Melanin, Pigment Conditions, and Suspicious-Lesion Referral
6 Cosmetic Chemistry, Ingredients, and Labels
Formulations, pH, pKa, and Acid-Equilibrium Calculations AHA, Salicylic, PHA, Enzyme, and TCA Comparisons Retinoids, Antioxidants, Peptides, and Growth-Factor Claims Delivery Systems, Ingredient Labels, Irritation, and Allergy
7 Consultation, Phototype, Aging, and Skin Observation
Consultation, Medicines, Contraindications, and Consent Fitzpatrick Phototype, Pigment History, and Individual Risk Intrinsic and Extrinsic Aging, Scales, and Examination Tools
8 Chemical Exfoliation: Selection, Endpoints, and Care
Superficial Chemical Exfoliation: Selection and Application Jessner, Modified Jessner, and TCA: Selection and Exposure Peel Endpoints, Surface Residue, Neutralization, and Adverse Events Pre-Peel Care, Recovery Instructions, and Complication Referral
9 Mechanical and Fluid-Assisted Exfoliation
Crystal and Diamond Microdermabrasion: Equipment and Controls Microdermabrasion: Preparation, Technique, and Adverse Responses Dermaplaning Awareness and Blade Safety Hydrodermabrasion and Physical Exfoliation Systems
10 Electrical, Acoustic, RF, and Pressure Devices
Electrical Measurements, Circuits, and Treatment-Room Safety Galvanic Current: Desincrustation and Iontophoresis High Frequency and Ultrasonic Spatulas: Recognition and Safe Use Microcurrent: Units, Evidence, Products, and Applicator Control RF, Device-Assisted Lymphatic Methods, and Product Selection
11 LED, Optical Physics, and Medical Laser Awareness
Light Physics, Spectrum, and Tissue Interactions LED Phototherapy: Selection, Dose, Products, and Protection Laser and IPL Physics: Selectivity and Medical Boundaries Hair Cycles, Laser Reduction, and Eye and Plume Safety
12 Lymphatic Methods and Body Services
Manual Lymphatic Drainage: Movements, Sequence, and Practical Skills MLD Client Selection: Edema, Medical Coordination, and Referral Body Scrubs, Wraps, Cellulite, and Hydrotherapy
13 Current Virginia Licensing, Scope, and Facility Rules
Virginia Licensing Routes, Training, Renewal, and Reinstatement Virginia Scope: Exfoliators, Lasers, and Medical Authority Virginia Sanitation: Tools, Linens, Chemicals, and Blood Spills Virginia Spa, School, Instructor, Records, and Discipline Rules
14 Advanced Therapy and Medical Procedure Awareness
Cryogenic, Ayurvedic, Plant, and Algae Therapy Awareness Medical Aesthetics Vocabulary and Care Coordination Microneedling, Ultrasound, PRP, and PRF Awareness
15 Service Environments, Documentation, and Extractions
Protocols in Clinical, Spa, and Home Environments Protocol Records, Consent, Assessment, and Follow-Up Extractions: Lesion Selection, Implements, and Safe Technique
16 Hair Removal and Aromatherapy
Waxing, Sugaring, Tweezing, and Electrolysis Awareness Hair-Removal Regions, Skin Support, and Client Protection Aromatherapy: Products, Exposure Routes, and Sensory Services
Acne Mechanisms, Severity Descriptions, and Cosmetic Decisions
Key Takeaways Explain This Topic AI
Follicular keratinization, sebum, microbial interactions, and inflammation contribute to acne.
Severity systems vary; grade labels do not prescribe one cosmetic treatment.
Deep painful, scarring, or significantly inflamed disease needs medical assessment.
Medicine precautions and Virginia scope remain relevant to any later cosmetic plan.
Last updated: October 2026
Acne Vulgaris Pathophysiology
Acne vulgaris is a chronic inflammatory disorder of the pilosebaceous unit affecting more than 85% of adolescents and a rising proportion of adult women. In advanced clinical practice, successful treatment depends on mastering the four interdependent biological pillars governing follicular obstruction, microbial colonization, and tissue destruction.
- The Four Etiologic Pillars
- 1. Follicular Retention Hyperkeratinization
Normal follicular infundibula shed single corneocytes that travel to the surface within the sebum stream. In acne-prone individuals, infundibular keratinocytes proliferate excessively and exhibit abnormal intercellular adhesion. Altered differentiation, adhesion, inflammation, and sebum composition can contribute to a cohesive cellular impaction that occludes the follicular ostium.
2. Androgen-Mediated Sebum Hypersecretion
Sebaceous glands are highly responsive to circulating androgens. Free testosterone and dehydroepiandrosterone sulfate (DHEA-S) enter sebocytes, where the enzyme 5-alpha reductase (predominantly type 1 in cutaneous tissue) converts testosterone into 5-alpha-dihydrotestosterone (DHT). DHT binds to intracellular androgen receptors with high affinity, stimulating sebocyte proliferation and profuse sebum production rich in squalene, wax esters, and triglycerides.
3. Microbial Proliferation ( Cutibacterium acnes )
Follicular occlusion creates an anaerobic, lipid-dense canal. This environment favors interactions involving Cutibacterium acnes (formerly Propionibacterium acnes ), an aerotolerant, gram-positive anaerobic rod resident in the pilosebaceous unit. C. acnes secretes lipases that hydrolyze sebum triglycerides into irritating free fatty acids, accelerating comedogenesis.
4. Perifollicular Inflammatory Cascade
C. acnes activates Toll-like Receptor 2 (TLR-2) on perifollicular macrophages and keratinocytes. This triggers nuclear factor kappa B (NF-κB), stimulating pro-inflammatory cytokine release:
Interleukin-1 alpha (IL-1α): Promotes infundibular hyperkeratinization.
Interleukin-8 (IL-8): A signal promoting neutrophil recruitment. Interleukin-12 (IL-12) contributes to cell-mediated immune responses; it is not interchangeable with IL-8 as a neutrophil chemotactic signal.
Tumor Necrosis Factor-alpha (TNF-α): Increases microvascular permeability.
Recruited neutrophils release matrix metalloproteinases (MMPs) and reactive oxygen species (ROS) that degrade the follicular wall. When the wall ruptures, lipids, keratin, and antigens extravasate into the dermis, converting a microscopic impaction into an intense inflammatory reaction.
Progression of Follicular Lesions
Microcomedo: The subclinical, microscopic precursor impaction.
Closed Comedo (Whitehead): An elevated, non-inflammatory papule (1–3 mm) with an intact, microscopic follicular ostium trapping unoxidized sebum and keratin.
Open Comedo (Blackhead): A non-inflammatory lesion with a dilated orifice. The dark plug results from melanin oxidation and compacted lipids upon air contact, not trapped dirt.
Inflammatory Papule: A tender, erythematous elevation (< 5 mm) resulting from partial follicular rupture and dermal infiltration.
Pustule: A superficial lesion filled with purulent exudate and necrotic neutrophils.
Nodule & Pseudocyst: Deep follicular rupture into the reticular dermis. Nodules are firm, painful masses (> 5 mm); pseudocysts are fluctuant inflammatory cavities lacking epithelial linings. Both carry severe scarring risk.
Severity descriptions and role boundaries
Educational four-grade systems often progress from mainly comedonal findings through increasing inflammation to deep nodular or cyst-like disease. Clinical severity systems vary, so a grade number is meaningful only within the named framework. Do not diagnose the entire condition from one count or assume every client in a grade should receive the same peel.
Record the observed mix of comedones, inflamed lesions, depth, distribution, pain, and reported scarring. Significant inflammation, painful deep lesions, rapid worsening, or scarring warrants medical assessment. The cosmetic role should support appropriate care rather than promise to cure disease.
Variants described in medical literature
Acne Cosmetica: Low-grade closed comedones associated with some cosmetic formulations in susceptible clients. Ingredient names alone do not provide a universal comedogenicity prediction.
Acne Mechanica: Flare-ups triggered by heat, pressure, and friction from equipment (e.g., sports helmets, straps, facial masks).
Acne Excoriée: Compulsive picking and scratching of minor or imagined blemishes, leaving crusts, linear excoriations, and scars.
Extraction choices
Only suitable superficial noninflamed impactions are candidates for trained cosmetic extraction. Avoid inflamed pustules, deep lesions, open skin, and unexplained bumps. Do not puncture or squeeze a lesion to establish what it contains. Stop when material does not release easily, or when pain, bruising, or bleeding occurs.
Virginia scope and sanitation apply regardless of severity terminology. A theory reference to a lancet does not establish legal authority for incision or drainage. Use only a lawful suitable method and refer targets needing medical evaluation.
Medicines, barrier tolerance, and medical coordination
Acne care may include benzoyl peroxide, topical retinoids, antibiotics, hormonal approaches, or isotretinoin under appropriate medical guidance. These have different mechanisms and precautions. Record actual use and ask about irritation. The esthetician should not prescribe or independently stop treatment to qualify a client for a peel.
Current isotretinoin labeling and patient guidance warn against waxing and skin-resurfacing procedures during treatment and for at least six months afterward. Do not replace that warning with a universal six-to-twelve-month legal ban on every procedure, or assume a softer abrasive bypasses it. Obtain appropriate provider guidance for the actual requested service.
Recent topical actives and other procedures can reduce tolerance. There is no universal three-to-five-day washout that establishes safety for every prescription, product, or client. Coordinate changes with the prescriber and follow device/product restrictions. Persistent irritation warrants deferral and appropriate care.
A client with painful inflammatory lesions asks for 20% TCA soon after isotretinoin. The request has multiple problems: current skin suitability, medication precautions, and Virginia's explicit requirement that TCA be less than 20%. Do not offer LED or extraction as an automatic treatment for the medical problem. Refer for appropriate acne care, then reassess any later lawful cosmetic service.
Home guidance should favor a compatible gentle routine, realistic expectations, and avoiding picking or repeated aggressive exfoliation. Sun protection supports care but does not erase an injured barrier. Document observed condition, service exclusions, medicines reported, and referral. On the exam, distinguish acne pathogenesis from the choice to perform a procedure; knowing a mechanism does not establish that a particular client is suitable.
Sources and current rules
Virginia exfoliators ; AAD isotretinoin guidance . Checked October 7, 2026.
Experimental TLR2 and acne cytokine study . Checked October 7, 2026.